Clinical importance of aspirin and clopidogrel resistance
Authors:
- Gergely FeherGergely Feher
- Andrea FeherAFAndrea Feher
- Gabriella PuschGPGabriella Pusch
- Katalin KoltaiKKKatalin Koltai
- Antal TiboldATAntal Tibold
- Beata GasztonyiBGBeata Gasztonyi
- Elod PappEPElod Papp
- Laszlo SzaparyLSLaszlo Szapary
- Gabor KesmarkyGKGabor Kesmarky
- Kalman TothKTKalman Toth
Open Access
- 1 January 2010
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 2 (7) , 171-186
Abstract
Clinical importance of aspirin and clopidogrel resistanceKeywords
This publication has 127 references indexed in Scilit:
- Meta‐analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrelAlimentary Pharmacology & Therapeutics, 2010
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Pharmacogenetics of aspirin resistance: a comprehensive systematic reviewBritish Journal of Clinical Pharmacology, 2008
- Drug interaction with anti-mycobacterial treatment as a cause of clopidogrel resistance2008
- Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotininTransfusion, 2008
- Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysisBMJ, 2008
- Consistent platelet inhibition during long-term maintenance-dose clopidogrel therapy among 359 compliant outpatients with documented vascular diseaseAmerican Heart Journal, 2007
- Does Glycoprotein IIIa Gene (PlA) Polymorphism Influence Clopidogrel Resistance?Drugs & Aging, 2007
- Aspirin ResistanceDrugs & Aging, 2006